Defensive Investors are defined as investors who are not able or willing to do substantial research into individual investments, and therefore need to select only the companies that present the least amount of risk.

Despite concerns about global economic growth and a persistent lack of inflation, especially given all the global quantitative easing, fundamentals for U.S. stocks still look good.

In part 20 of my 54 part series on Dividend Aristocrats, I take a closer look at the operations of Cardinal Health. In this article, you will see the company's (very strong) competitive advantage, growth prospects, and relative valuation.

CAH is one of the leading providers of products and services to healthcare providers and manufacturers to help them improve the efficiency and quality of healthcare.

When Steve Brozak performs diligence on biotech stocks, he's always looking for an angle. Brozak, president and managing director at WBB Securities, wants to see how new technology platforms and novel ideas fit into tomorrow's healthcare system.

September E-mini S&Ps (ESU14 +0.36%) this morning are up +0.35% and European stocks are up +0.72% as Portuguese government bonds rallied and corporate credit risk in Europe fell for the first time in 5 days...